TY - JOUR
T1 - Functional connectivity signatures of major depressive disorder
T2 - machine learning analysis of two multicenter neuroimaging studies
AU - Gallo, Selene
AU - el-Gazzar, Ahmed
AU - Zhutovsky, Paul
AU - Thomas, Rajat M.
AU - Javaheripour, Nooshin
AU - Li, Meng
AU - Bartova, Lucie
AU - Bathula, Deepti
AU - Dannlowski, Udo
AU - Davey, Christopher
AU - Frodl, Thomas
AU - Gotlib, Ian
AU - Grimm, Simone
AU - Grotegerd, Dominik
AU - Hahn, Tim
AU - Hamilton, Paul J.
AU - Harrison, Ben J.
AU - Jansen, Andreas
AU - Kircher, Tilo
AU - Meyer, Bernhard
AU - Nenadić, Igor
AU - Olbrich, Sebastian
AU - Paul, Elisabeth
AU - Pezawas, Lukas
AU - Sacchet, Matthew D.
AU - Sämann, Philipp
AU - Wagner, Gerd
AU - PsyMRI
AU - Walter, Henrik
AU - Walter, Martin
AU - van Wingen, Guido
N1 - Funding Information: GvW received research funding from Philips. The other authors declare no competing interests. Funding Information: This work was supported by the Netherlands Organization for Scientific Research (NWO; 628.011.023); Philips Research; ZonMW (Vidi; 016.156.318). The access of the UKbioBank data was granted under the application number 30091. Data collection was supported by Swedish Research Council; ALF grant from Region Östergötland; the Phyllis and Jerome Lyle Rappaport Foundation, Ad Astra Chandaria Foundation, BIAL Foundation, Brain and Behavior Research Foundation, Anonymous donors, and the Center for Depression, Anxiety, and Stress Research at McLean Hospital; The German Research Foundation (DFG, grant FOR2107 DA1151/5-1 and DA1151/5-2 to UD; SFB-TRR58, Projects C09 and Z02 to UD) and the Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Münster (grant Dan3/012/17 to UD); European Commission (grant number H2020-634541); German Research Foundation (GR 4510/2-1); Australian National Health and Medical Research Council of Australia (NHMRC) Project Grants 1064643 (principal investigator, BJH) and 1024570 (principal investigator, CGD); Austrian Science Fund (FWF, grant nr. KLI 597-827, KLI-148-B00, F3514-B1); Science Foundation Ireland (SFI); The German Research Foundation (DFG WA1539/4-1). This work also acknowledges the DIRECT consortium for providing the Rest-Meta-MDD dataset. Publisher Copyright: © 2023, The Author(s).
PY - 2023/7
Y1 - 2023/7
N2 - The promise of machine learning has fueled the hope for developing diagnostic tools for psychiatry. Initial studies showed high accuracy for the identification of major depressive disorder (MDD) with resting-state connectivity, but progress has been hampered by the absence of large datasets. Here we used regular machine learning and advanced deep learning algorithms to differentiate patients with MDD from healthy controls and identify neurophysiological signatures of depression in two of the largest resting-state datasets for MDD. We obtained resting-state functional magnetic resonance imaging data from the REST-meta-MDD (N = 2338) and PsyMRI (N = 1039) consortia. Classification of functional connectivity matrices was done using support vector machines (SVM) and graph convolutional neural networks (GCN), and performance was evaluated using 5-fold cross-validation. Features were visualized using GCN-Explainer, an ablation study and univariate t-testing. The results showed a mean classification accuracy of 61% for MDD versus controls. Mean accuracy for classifying (non-)medicated subgroups was 62%. Sex classification accuracy was substantially better across datasets (73–81%). Visualization of the results showed that classifications were driven by stronger thalamic connections in both datasets, while nearly all other connections were weaker with small univariate effect sizes. These results suggest that whole brain resting-state connectivity is a reliable though poor biomarker for MDD, presumably due to disease heterogeneity as further supported by the higher accuracy for sex classification using the same methods. Deep learning revealed thalamic hyperconnectivity as a prominent neurophysiological signature of depression in both multicenter studies, which may guide the development of biomarkers in future studies.
AB - The promise of machine learning has fueled the hope for developing diagnostic tools for psychiatry. Initial studies showed high accuracy for the identification of major depressive disorder (MDD) with resting-state connectivity, but progress has been hampered by the absence of large datasets. Here we used regular machine learning and advanced deep learning algorithms to differentiate patients with MDD from healthy controls and identify neurophysiological signatures of depression in two of the largest resting-state datasets for MDD. We obtained resting-state functional magnetic resonance imaging data from the REST-meta-MDD (N = 2338) and PsyMRI (N = 1039) consortia. Classification of functional connectivity matrices was done using support vector machines (SVM) and graph convolutional neural networks (GCN), and performance was evaluated using 5-fold cross-validation. Features were visualized using GCN-Explainer, an ablation study and univariate t-testing. The results showed a mean classification accuracy of 61% for MDD versus controls. Mean accuracy for classifying (non-)medicated subgroups was 62%. Sex classification accuracy was substantially better across datasets (73–81%). Visualization of the results showed that classifications were driven by stronger thalamic connections in both datasets, while nearly all other connections were weaker with small univariate effect sizes. These results suggest that whole brain resting-state connectivity is a reliable though poor biomarker for MDD, presumably due to disease heterogeneity as further supported by the higher accuracy for sex classification using the same methods. Deep learning revealed thalamic hyperconnectivity as a prominent neurophysiological signature of depression in both multicenter studies, which may guide the development of biomarkers in future studies.
UR - http://www.scopus.com/inward/record.url?scp=85148366299&partnerID=8YFLogxK
U2 - https://doi.org/10.1038/s41380-023-01977-5
DO - https://doi.org/10.1038/s41380-023-01977-5
M3 - Article
C2 - 36792654
SN - 1359-4184
VL - 28
SP - 3013
EP - 3022
JO - Molecular psychiatry
JF - Molecular psychiatry
IS - 7
ER -